Development and validation of a diagnostic model for cerebral small vessel disease among rural older adults in China

Front Neurol. 2024 Jul 5:15:1388653. doi: 10.3389/fneur.2024.1388653. eCollection 2024.

Abstract

Objectives: Cerebral small vessel disease (CSVD) visible on MRI can be asymptomatic. We sought to develop and validate a model for detecting CSVD in rural older adults.

Methods: This study included 1,192 participants in the MRI sub-study within the Multidomain Interventions to Delay Dementia and Disability in Rural China. Total sample was randomly divided into training set and validation set. MRI markers of CSVD were assessed following the international criteria, and total CSVD burden was assessed on a scale from 0 to 4. Logistic regression analyses were used to screen risk factors and develop the diagnostic model. A nomogram was used to visualize the model. Model performance was assessed using the area under the receiver-operating characteristic curve (AUC), calibration plot, and decision curve analysis.

Results: The model included age, high blood pressure, white blood cell count, neutrophil-to-lymphocyte ratio (NLR), and history of cerebral infarction. The AUC was 0.71 (95% CI, 0.67-0.76) in the training set and 0.69 (95% CI, 0.63-0.76) in the validation set. The model showed high coherence between predicted and observed probabilities in both the training and validation sets. The model had higher net benefits than the strategy assuming all participants either at high risk or low risk of CSVD for probability thresholds ranging 50-90% in the training set, and 65-98% in the validation set.

Conclusion: A model that integrates routine clinical factors could detect CSVD in older adults, with good discrimination and calibration. The model has implication for clinical decision-making.

Keywords: blood pressure; cerebral small vessel disease; diagnostic model; inflammation; population-based study.

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The MIND-China Project was financially supported by the STI2030-Major Project (Grant nos.: 2021ZD0201808 and 2022ZD0211600) and by additional grants from the National Key R&D Program of China (Grant no. 2017YFC1310100), the National Nature Science Foundation of China (grants nos. 82171175, 82011530139, and 82001120), the Academic Promotion Program of Shandong First Medical University (Grant nos. 2019QL020 and 2020RC009), and the Taishan Scholar Program of Shandong Province (Grant nos. ts20190977 and Tsqn201909182). This work was further supported by additional grants from the Nature Science Foundation of Shandong Province (Grant no.: ZR2020QH098), the Integrated Traditional Chinese and Western Medicine Program in Shandong Province (YXH2019ZXY008) and Shandong Provincial Key Research and Development Program (Grant no.: 2021LCZX03). The funding agencies had no role in the study design, data collection and data analysis, the writing of this article, and in the decision to submit the work for publication.